New tentative approval for Sandoz Inc drug rifaximin
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound. Drug patent litigation for… Source The post New tentative approval for Sandoz Inc drug rifaximin appeared first on Biotechblog ..read more
Visit website
New patent for Catalyst Pharms drug FYCOMPA
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
Annual Drug Patent Expirations for FYCOMPA Fycompa is a drug marketed by Catalyst Pharms and is included in two NDAs. It is available from two suppliers. There are two patents… Source The post New patent for Catalyst Pharms drug FYCOMPA appeared first on Biotechblog ..read more
Visit website
New tentative approval for Zydus Pharms drug empagliflozin;linagliptin;metformin hydrochloride
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com Source The post New tentative approval for Zydus Pharms drug empagliflozin;linagliptin;metformin hydrochloride appeared first on Biotechblog ..read more
Visit website
New patent for Pacira Pharms drug EXPAREL
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
Annual Drug Patent Expirations for EXPAREL Exparel is a drug marketed by Pacira Pharms Inc and is included in one NDA. It is available from one supplier. There are ten… Source The post New patent for Pacira Pharms drug EXPAREL appeared first on Biotechblog ..read more
Visit website
New patent for Bristol drug ZEPOSIA
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
Annual Drug Patent Expirations for ZEPOSIA Zeposia is a drug marketed by Bristol and is included in one NDA. It is available from one supplier. There are five patents protecting… Source The post New patent for Bristol drug ZEPOSIA appeared first on Biotechblog ..read more
Visit website
Which pharmaceutical drugs have the most drug patents in Argentina?
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
This chart shows the drugs with the most patents in Argentina. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… Source The post Which pharmaceutical drugs have the most drug patents in Argentina? appeared first on Biotechblog ..read more
Visit website
New tentative approval for Sandoz Inc drug rifaximin
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound. Drug patent litigation for… Source The post New tentative approval for Sandoz Inc drug rifaximin appeared first on Biotechblog ..read more
Visit website
Which pharmaceutical drugs have the most drug patents in Colombia?
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
This chart shows the drugs with the most patents in Colombia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… Source The post Which pharmaceutical drugs have the most drug patents in Colombia? appeared first on Biotechblog ..read more
Visit website
New tentative approval for Sandoz Inc drug rifaximin
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound. Drug patent litigation for… Source The post New tentative approval for Sandoz Inc drug rifaximin appeared first on Biotechblog ..read more
Visit website
New tentative approval for Zydus Pharms drug empagliflozin;linagliptin;metformin hydrochloride
BiotechBlog
by DrugPatentWatch – Make Better Decisions
1w ago
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com Source The post New tentative approval for Zydus Pharms drug empagliflozin;linagliptin;metformin hydrochloride appeared first on Biotechblog ..read more
Visit website

Follow BiotechBlog on FeedSpot

Continue with Google
Continue with Apple
OR